tiprankstipranks
Advertisement
Advertisement

IMDX Stock Latest News

IMDX Earnings this Week: How Will it Perform?
Pre-EarningsIMDX Earnings this Week: How Will it Perform?
14h ago
IMDX
GALACTIC Trial: IMDX Advances Non‑Invasive Kidney Transplant Monitoring
PremiumCompany Announcements
GALACTIC Trial: IMDX Advances Non‑Invasive Kidney Transplant Monitoring
9d ago
IMDX
Insight Molecular Diagnostics highlights Lancet study on GraftAssure assay
PremiumThe Fly
Insight Molecular Diagnostics highlights Lancet study on GraftAssure assay
16d ago
IMDX
Insight Molecular Diagnostics Shareholders Back Board and Incentive Plan
PremiumCompany Announcements
Insight Molecular Diagnostics Shareholders Back Board and Incentive Plan
2M ago
8K
IMDX
Insight Molecular Diagnostics Balances Progress and Cash Burn
PremiumCompany Announcements
Insight Molecular Diagnostics Balances Progress and Cash Burn
3M ago
IMDX
OncoCyte’s Earnings Call Maps Risky Path to Launch
PremiumCompany AnnouncementsOncoCyte’s Earnings Call Maps Risky Path to Launch
3M ago
IMDX
Insight Molecular Diagnostics Maintained at Buy as GraftAssure Platform Gains Traction; $9 Price Target Reaffirmed
Premium
Ratings
Insight Molecular Diagnostics Maintained at Buy as GraftAssure Platform Gains Traction; $9 Price Target Reaffirmed
3M ago
IMDX
Insight Molecular Corrects Bylaws Disclosure in Annual Report
Premium
Company Announcements
Insight Molecular Corrects Bylaws Disclosure in Annual Report
3M ago
8K
IMDX
Insight Molecular Diagnostics: Building Momentum with GraftAssure Platform and Favorable Risk‑Reward Supporting Buy Rating
PremiumRatings
Insight Molecular Diagnostics: Building Momentum with GraftAssure Platform and Favorable Risk‑Reward Supporting Buy Rating
4M ago
IMDX
OncoCyte Earnings Call: GraftAssureDx Drives Pivot
PremiumCompany Announcements
OncoCyte Earnings Call: GraftAssureDx Drives Pivot
4M ago
IMDX
Buy Rating on IMDX Driven by Strong GraftAssure Traction, Upcoming FDA Catalyst, and Solid Balance Sheet
PremiumRatings
Buy Rating on IMDX Driven by Strong GraftAssure Traction, Upcoming FDA Catalyst, and Solid Balance Sheet
4M ago
IMDX
Insight Molecular Diagnostics submits GraftAssureDx for FDA review
PremiumThe Fly
Insight Molecular Diagnostics submits GraftAssureDx for FDA review
5M ago
IMDX
Insight Molecular Diagnostics reports Q4 EPS (27c) vs. (28c) last year
PremiumThe FlyInsight Molecular Diagnostics reports Q4 EPS (27c) vs. (28c) last year
5M ago
IMDX
OCX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
OCX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
5M ago
IMDX
Insight Molecular Diagnostics highlights publication of study on GraftAssure
Premium
The Fly
Insight Molecular Diagnostics highlights publication of study on GraftAssure
5M ago
IMDX
Insight Molecular Diagnostics completes milestones advancing GraftAssureDx
PremiumThe Fly
Insight Molecular Diagnostics completes milestones advancing GraftAssureDx
5M ago
IMDX
Insight Molecular Diagnostics: GraftAssureIQ Validation and Hospital Adoption Set Up 2026 as a Growth Inflection Year
PremiumRatings
Insight Molecular Diagnostics: GraftAssureIQ Validation and Hospital Adoption Set Up 2026 as a Growth Inflection Year
5M ago
IMDX
Insight Molecular Diagnostics Signs Quest Specimen Collection Agreement
PremiumCompany Announcements
Insight Molecular Diagnostics Signs Quest Specimen Collection Agreement
5M ago
8K
IMDX
Insight Molecular Diagnostics price target raised to $12 from $8 at Lake Street
PremiumThe Fly
Insight Molecular Diagnostics price target raised to $12 from $8 at Lake Street
6M ago
IMDX
Insight Molecular Diagnostics Raises Capital to Advance Transplant R&D
PremiumCompany AnnouncementsInsight Molecular Diagnostics Raises Capital to Advance Transplant R&D
6M ago
8K
IMDX
Insight Molecular Diagnostics Provides Updated Investor Presentation Materials
Premium
Company Announcements
Insight Molecular Diagnostics Provides Updated Investor Presentation Materials
6M ago
8K
IMDX
Insight Molecular Diagnostics prices 4.53M shares at $5.75 in direct offering
Premium
The Fly
Insight Molecular Diagnostics prices 4.53M shares at $5.75 in direct offering
6M ago
IMDX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >